Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: Systematic review and meta-analysis

British Journal of Psychiatry

Volumn 205, Issue 2, 2014, Pages 88-94

  Penttilä, Matti ^a   Jaä̈skel̈ainen, Erika ^a   Hirvonen, Noora ^a   Isohanni, Matti ^a   Miettunen, Jouko ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905666445     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.113.127753     Document Type: Review

References (46)

1. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 2013; 39: 1296-306.
2. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-83. (Pubitemid 41248376)
3. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804. (Pubitemid 41428609)
4. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlaeger J, le Quach P, et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 2008; 65: 762-71. (Pubitemid 351957702)
5. Gafoor R, Nitsch D, McCrone P, Craig TKJ, Garety PA, Power P, et al. Effect of early intervention on 5-year outcome in non-affective psychosis. Br J Psychiatry 2010; 196: 372-6.
6. Hegelstad WT, Larsen TK, Auestad B, Evensen J, Haahr U, Joa I, et al. Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. Am J Psychiatry 2012; 169: 374-80.
7. PenttiläM, Miettunen J, Koponen H, Kyllönen M, Veijola J, Isohanni M, et al. Association between the duration of untreated psychosis and short- and long-term outcome in schizophrenia within the Northern Finland 1966 Birth Cohort. Schizophr Res 2013; 143: 3-10.
8. Norman RMG, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry 2001; 179: 340-5. (Pubitemid 32996044)
9. Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry 2010; 44: 921-8.
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. (Pubitemid 30214957)
11. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2004; 28: 2-13.
12. Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 2006; 36: 1349-62. (Pubitemid 44355971)
13. Shrivastava A, Johnston M, Shah N, Bureau Y. Redefining outcome measures in schizophrenia: integrating social and clinical parameters. Curr Opin Psychiatry 2010; 23: 120-6.
14. Parellada M, Boada L, Fraguas D, Reig S, Castro-Fornieles J, Moreno D, et al. Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull 2011; 37: 38-51.
15. Nielssen OB, Malhi GS, McGorry PD, Large MM. Overview of violence to self and others during the first episode of psychosis. J Clin Psychiatry 2012; 73: e580-7.
16. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-9. (Pubitemid 40343909)
17. Faerden A, Nesvåg R, Marder SR. Definitions of the term 'recovered' in schizophrenia and other disorders. Psychopathology 2008; 41: 271-8.
18. Rosenthal R. Parametric measures of effect size. In The Handbook of Research Synthesis (eds H Cooper, LV Hedges). Sage, 1994.
19. Rosenthal R, Rosnow RL, Rubin DB. Contrasts and Effect Sizes in Behavioral Research: A Correlational Approach: 212. Cambridge University Press, 2000.
20. Cohen J. A power primer. Psychol Bull 1992; 112: 155-9.
21. Stata Corporation. Stata User's Guide, Release 11. Stata Press; 2009.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60. (Pubitemid 37088507)
23. Sterne J. Meta-Analysis in Stata: An Updated Collection from the Stata Journal. Stata Press, 2009.
24. Röpcke B, Eggers C. Early-onset schizophrenia: a 15-year follow-up. Eur Child Adolesc Psychiatry 2005; 14: 341-50.
25. Górna K, Jaracz K, Rybakowski F, Rybakowski J. Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study. Qual Life Res 2008; 17: 237-47.
26. White C, Stirling J, Hopkins R, Morris J, Montague L, Tantam D, et al. Predictors of 10-year outcome of first-episode psychosis. Psychol Med 2009; 39: 1447-56.
27. Hill M, Crumlish N, Clarke M, Whitty P, Owens E, Renwick L, et al. Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years. Schizophr Res 2012; 141: 215-21.
28. Boonstra N, Klaassen R, Sytema S, Marshall M, De Haan L, Wunderink L, et al. Duration of untreated psychosis and negative symptoms - a systematic review and meta-analysis of individual patient data. Schizophr Res 2012; 142: 12-9.
29. McGlashan TH. Premorbid adjustment, onset types, and prognostic scaling: still informative? Schizophr Bull 2008; 34: 801-5.
30. Compton MT, Chien VH, Leiner AS, Goulding SM, Weiss PS. Mode of onset of psychosis and family involvement in help-seeking as determinants of duration of untreated psychosis. Soc Psychiatry Psychiatr Epidemiol 2008; 43: 975-82.
31. Compton MT, Gordon TL, Weiss PS, Walker EF. The 'doses' of initial, untreated hallucinations and delusions: a proof-of-concept study of enhanced predictors of first-episode symptomatology and functioning relative to duration of untreated psychosis. J Clin Psychiatry 2011; 72: 1487-93.
32. Tandon R. Antipsychotics in the treatment of schizophrenia: an overview. J Clin Psychiatry 2011; 72 (supp 1): 4-8.
33. Chiliza B, Asmal L, Emsley R. Early intervention in schizophrenia in developing countries: focus on duration of untreated psychosis and remission as a treatment goal. Int Rev Psychiatry 2012; 24: 483-8.
34. Moncrieff J. Questioning the 'neuroprotective' hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? Br J Psychiatry 2011; 198: 85-7.
35. Ichinose H, Nakane Y, Nakane H, Kinoshita H, Ohta Y, Honda S. Nagasaki Schizophrenia Study: relationship between ultralong-term outcome (after 28 years) and duration of untreated psychosis. Acta Med Nagasaki 2010; 54: 59-66.
36. Bottlender R, Sato T, Jager M, Wegener U, Wittmann J, Strauss A, et al. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 2003; 62: 37-44. (Pubitemid 36603320)
37. Chang WC, Tang JY, Hui CL, Lam MM, Wong GH, Chan SK, et al. Duration of untreated psychosis: relationship with baseline characteristics and threeyear outcome in first-episode psychosis. Psychiatry Res 2012; 198: 360-5.
38. Norman RM, Manchanda R, Windell D, Harricharan R, Northcott S, Hassall L. The role of treatment delay in predicting 5-year outcomes in an early intervention program. Psychol Med 2012; 42: 223-33.
39. Selten JP, Veen ND, Hoek HW, Laan W, Schols D, van der Tweel I, et al. Early course of schizophrenia in a representative Dutch incidence cohort. Schizophr Res 2007; 97: 79-87. (Pubitemid 350088385)
40. Rupp C, Fletcher E. A five to ten year follow-up study of 641 schizophrenic cases. Am J Psychiatry 1940; 96: 877-88.
41. Achte K. On prognosis and rehabilitation in schizophrenic and paranoid psychoses: a comparative follow-up study of two series of patients first admitted to hospital in 1950 and 1960 respectively. Acta Psychiatr Scand 1967; 43 : 9-217.
42. Scully PJ, Coakley G, Kinsella A, Waddington JL. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med 1997; 27: 1303-10. (Pubitemid 27494096)
43. Jeppesen P, Petersen L, Thorup A, Abel MB, Øhlenschlaeger J, Christensen TØ, et al. The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol Med 2008; 38: 1157-66. (Pubitemid 351950154)
44. Petersen L, Thorup A, Øqhlenschlaeger J, Christensen TØ, Jeppesen P, Krarup G, et al. Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Can J Psychiatry 2008; 53: 660-70.
45. Tomotake M. Quality of life and its predictors in people with schizophrenia. J Med Invest 2011; 58: 167-74.
46. Thorup A, Petersen L, Jeppesen P, Nordentoft M. The quality of life among first-episode psychotic patients in the OPUS trial. Schizophr Res 2010; 116: 27-34.